Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients [Oct 26, 2023] Misset et al. NEJM nejm.org/doi/full/10.10… #NCT0455847 #COVID19 CP #COVID19

Early Outpatient Treatment for Covid-19 with Convalescent Plasma [Mar 30, 2022] David J Sullivan et al. NEJM ow.ly/4SPa50IwB6P #NCT04373460 #COVID19 CP #COVID19

Follow up study of participants in COVID-19 Convalescent plasma RCT associates post-COVID (long covid) with increased IL-6 and notes reduced symptoms at day 90 for those treated with CCP in first 5 days. Consistent with CCP antiviral effect
medrxiv.org/content/10.110… #COVID19CP

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a RCT [Dec 29, 2022] Claudia Denkinger et al HT Michael Joyner Nature Cancer #COVID19 CP #COVID19 nCancer #IDonc #COVID19
nature.com/articles/s4301…

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] Mike Thompson, MD, PhD, FASCO & Jeff Henderson MDPhD et al. Jack Senefeld Dimpy Shah MD, PhD @hemoncwarner COVID-19 and Cancer Consortium (CCC19) Registry - JAMA Oncology ow.ly/SJJu50FcCmD #COVID19 CP #CCC19 #COVID19 nCancer #COVID19 #IDonc

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] Mike Thompson, MD, PhD, FASCO & Jeff Henderson MDPhD et al. Jack Senefeld Dimpy Shah MD, PhD @hemoncwarner COVID-19 and Cancer Consortium (CCC19) Registry - JAMA Oncology ow.ly/SJJu50FcCmD #COVID19 CP #CCC19 #COVID19 nCancer #COVID19 #IDonc

#COVID19CP

Excellent reporting by Gabriella Vulakh, Brown University student on the recent developments with COVID-19 Convalescent Plasma ( #COVID19CP )
browndailyherald.com/article/2023/0…

Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials [Dec 29, 2023] Franchini et al. Daniele Focosi, MD PhD MSc Transfusion onlinelibrary.wiley.com/doi/10.1111/tr… #COVID19CP AABB Arturo Casadevall Jack Senefeld Michael Joyner

Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data [Jun 17, 2021] Greg Calip Rebecca Miksad, MD Sarkar JAMA Oncology ow.ly/wTHl50FcSHZ #COVID19 CP #COVID19 nCancer #COVID19 #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry ...real-world data should continue to play a crucial role...

New #mBio commentary: Igniting the slow burn of post-COVID conditions reviews new evidence for how antiviral therapies can affect post-COVID symptoms after acute infection. Jeff Henderson MDPhD #COVID19CP journals.asm.org/doi/10.1128/mb…

New today in CID: expert panel update on antibody therapy with COVID-19 convalescent plasma. Important for our post-monoclonal antibody moment. academic.oup.com/cid/advance-ar… Mike Thompson, MD, PhD, FASCO Michael Joyner Arturo Casadevall COVID-19 and Cancer Consortium (CCC19) Registry WUSM Pathology & Immunology Washington University ID Division #COVID19 CP #COVID19